Syneos Health

• A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

  Collaborator, Phase 2/3, Completed, 272 people, 10 Feb 2023

• NCT04900038

  Collaborator, Phase 2, Terminated, 85 people, 25 May 2021

• NCT04879368

  Collaborator, Phase 3, Completed, 462 people, 10 May 2021

• NCT03973840

  Collaborator, Phase 1, Completed, 13 people, 4 Jun 2019

• NCT03291002

  Collaborator, Phase 1, Status unknown, 98 people, 25 Sept 2017

• NCT02947685

  Collaborator, Phase 3, Active, not recruiting, 518 people, 28 Oct 2016

• A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

  Collaborator, Phase 3, Completed, 222 people, 29 Mar 2016

• NCT02588105

  Collaborator, Phase 1, Completed, 84 people, 27 Oct 2015

• NCT02487108

  Collaborator, Phase 3, Completed, 569 people, 1 Jul 2015

• NCT02380625

  Collaborator, Phase 1/2, Status unknown, 150 people, 5 Mar 2015

• NCT02081300

  Collaborator, Phase 3, Completed, 315 people, 7 Mar 2014

• NCT01714037

  Collaborator, Phase 1, Terminated, 82 people, 25 Oct 2012

• NCT01143064

  Collaborator, Phase 3, Completed, 1,195 people, 14 Jun 2010

• NCT00766363

  Collaborator, Phase 1, Completed, 49 people, 3 Oct 2008

• NCT00358566

  Collaborator, Phase 3, Terminated, 360 people, 1 Aug 2006

Sources: clinicaltrials.gov

• An adult proteomic signature associated with very low birth weight and chronic disease risk

  Consulting or advice, Fees or honoraria, 16 Sept 2026

• Trends in utilization of glucagon-like peptide‐1 receptor agonists, sodium-glucose cotransporter‐2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity

  Grants or research support, 20 Aug 2026

• Association between rheumatoid arthritis, frailty status, mortality and anti-cancer therapy: a retrospective SEER-Medicare analysis in patients with non-metastatic renal cell carcinoma

  Consulting or advice, Fees or honoraria, 11 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov